Hospital Acquired Infection Control Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 4.26 Billion |
| Market Size (2029) | USD 5.18 Billion |
| CAGR (2024 - 2029) | 3.97 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Hospital Acquired Infection Control Market Analysis
The Global Hospital Acquired Infection Control Market size is estimated at USD 4.26 billion in 2024, and is expected to reach USD 5.18 billion by 2029, growing at a CAGR of 3.97% during the forecast period (2024-2029).
The COVID-19 pandemic underlined the critical necessity of hand hygiene and the use of conventional infection control methods, as the World Health Organization and the Centers for Disease Control and Prevention (CDC) recommended, in reducing the number of hospital-acquired infections. Additionally, the article titled "Prevention of hospital-acquired infections: A construct during Covid-19 pandemic" published in September 2021, reported that in the Bihar state of India, data was collated from January 2019 to December 2020, catheter-associated urinary tract infections (CAUTI) rates were reduced by 28.01%; the central-line-associated bloodstream infections (CLABSI) rates declined by 37.61%; the surgical site infections (SSIs) rates were reduced by 62.39%, while the highest ventilator-associated pneumonia (VAP) rates were reported in November 2019. Thus, due to widespread precautions against COVID-19 to control infection, HAI was also reduced. Although to maintain the proper hygienic conditions and prevent infection, control measures were stringently followed. Thus, COVID-19 had a significant impact on the growth of the market.
Specific factors driving the market's growth include increased hospital stays due to chronic diseases and surgeries; a rise in the incidences of different types of hospital-acquired infections; and innovative technologies implemented in devices that control infection.
Hospital-acquired infections are usually caused by pathogens, which spread quickly in the body. Due to the patients' weak immune systems and poor conditions in a hospital, infections spread faster than chronic infections. According to the Centers for Disease Control and Prevention, Healthcare Associated Infection Progress Report 2020, there were nearly 18,416 surgical site infections reported in 2020 in the United States. It also reported that out of this 6.094 infections were during colon surgery and 2,173 occurred during hip arthroplasty. Such a high rate of surgical site infection creates the need for products to control HAIs and thus propels the growth of the market.
The launch of products by market players around the globe is also contributing to the growth of the market. For instance, in May 2020, Esco launched the Esco CelCulture CO2 Incubator with High Heat Sterilization (CCL-HHS). This new product adopts a 180°C dry heat sterilization system, proven effective in killing normally resistant fungi, bacterial spores, and vegetative cells that may contaminate the workspace. Such launches are expected to propel the growth of the market.
Furthermore, in November 2021, PURioLABS developed PURitALL, a high-level, portable disinfection cabinet designed to destroy infection microbes on high-touch equipment and supplies at the point of service and to prevent healthcare-associated infections (HAIs). Such launches drive the growth of the market.
Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, a lack of awareness regarding hospital-acquired infections and stringent regulatory requirements may hinder the growth of the market.
Hospital Acquired Infection Control Market Trends
This section covers the major market trends shaping the Hospital Acquired Infection Control Market according to our research experts:
Disinfectant Segment is Expected to Hold Significant Market Share Over the Forecast Period
Disinfection is a process that eliminates many or all pathogenic microorganisms, except bacterial spores, from inanimate objects. This is accomplished by the use of liquid chemicals or wet pasteurization. The efficiency of disinfection has been affected by several factors, each of which may limit the efficacy of the process.
The rising incidence of hospital-acquired infections, a growing geriatric population, and subsequent growth in the prevalence of chronic diseases and the increasing number of surgical procedures are expected to drive the segment growth. As per the study titled "Healthcare-Associated Infections: A New Pathology in Medical Practice?" published in February 2020, about 50% of hospital-acquired infections occur in the intensive care unit. Surface disinfectants play a crucial role in preventing these infections, thus will boost the segment growth in the near future.
Additionally, the launch of new products by the market players is also propelling the growth of the segment. For instance, in April 2020, ITC launched its product Savlon Surface Disinfectant Spray. Also, in February 2022, SC Johnson Professional launched its Quaternary Disinfectant Cleaner in a new easy-to-measure, squeeze and pour the bottle in North America. Thus, the launch of new products is also expected to contribute to the growth of the market segment.
Thus, owing to the abovementioned factors, the disinfectant segment of the market is expected to grow over the forecast period.
North America Dominates the Market and Expected to do Same Over the Forecast Period
North America is expected to hold a significant share owing to the increase in hospital stays due to chronic diseases and surgeries, the rising number of hospital admission, the increasing burden of hospital-acquired infection coupled with the innovative technologies implemented in devices that control infection, and others.
According to the Center for Disease Control and Prevention, in 2021, about a 24% increase in central line bloodstream infection (CLABSI) and a 35% increase in Ventilator-Associated Event (VAE) between 2019-2020. Thus, the increasing prevalence rate of hospital-acquired infections in the United States boosts the market growth in the region.
Additionally, the rise in chronic diseases such as cardiovascular diseases, cancer, and others requires extended hospital stays and surgeries. For instance, according to 2022 data by the American Health Association, there were approximately 33,356,853 hospital admissions in 2022. Many of these admissions were due to chronic diseases and critical procedures like heart bypass surgery. Thus, the increasing number of hospital admissions is expected to create the need for infection control products and thereby boost the market in the region.
Additionally, in February 2021, Penn Medicine opened its new Interventional Support Center (ISC), one of the largest instrument processing and surgical supply preparation facilities in Southwest Philadelphia, United States. The ISC is one of the first facilities of its kind in Pennsylvania where staff will both sterilize and package thousands of instruments each day in preparation for surgeries and procedures, from basic scissors and clamps to advanced robotic instruments. The establishment of such facilities is also expected to propel the growth of the market.
Thus, owing to the abovementioned factors, the studied market in the North American region is expected to project significant growth over the forecast period.
Hospital Acquired Infection Control Industry Overview
The hospital-acquired infection control market is highly competitive and consists of several players. Companies like 3M Company, Becton, Dickinson and Company, Belimed AG, Biomerieux Sa, Cantel Medical, Ethicon, Getinge Group, Kimberly-Clark Corporation, Sterigenics International LLC, and Steris Corporation, among others, hold a substantial market share in the hospital-acquired infection control market.
Hospital Acquired Infection Control Market Leaders
-
3M Company
-
Becton, Dickinson and Company
-
Biomerieux SA
-
Sterigenics International LLC
-
Johnson and Johnson(Ethicon)
*Disclaimer: Major Players sorted in no particular order
Hospital Acquired Infection Control Market News
- In June 2022, Sonoma Pharmaceuticals, Inc. and the MicroSafe Group DMCC reported that Nanocyn hospital-grade disinfectant has been added to the list of COVID-19 disinfectants maintained by the United States Environmental Protection Agency's List N.
- In March 2022, PDI launched Sani-24 Germicidal Disposable Wipe, Sani-HyPerCide Germicidal Disposable Wipe, and Sani-HyPerCide Germicidal Spray, innovative disinfectants to help infection prevention professionals in the fight against rising healthcare-associated infections (HAIs) as well as the ongoing battle against COVID-19.
Hospital Acquired Infection Control Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increase in Hospital Stay Due to Chronic Diseases and Surgeries
- 4.2.2 Rise in the Incidences of Different Types of Hospital Acquired Infections
- 4.2.3 Innovative Technologies Implemented in Devices that Control Infection
-
4.3 Market Restraints
- 4.3.1 Lack of Awareness Regarding Hospital Acquired Infection
- 4.3.2 Stringent Regulatory Requirements
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Sterilants
- 5.1.1.1 Heat Sterilization Equipment
- 5.1.1.2 Low Temperature Sterilization Equipment
- 5.1.1.3 Radiation Sterilization Equipment
- 5.1.1.4 Steam Sterilization
- 5.1.1.5 Other Sterilants
- 5.1.2 Disinfectants
- 5.1.3 Other Products
-
5.2 By Indication
- 5.2.1 Hospital Acquired Pneumonia
- 5.2.2 Bloodstream Infections
- 5.2.3 Surgical Site Infections
- 5.2.4 Gastrointestinal Infections
- 5.2.5 Urinary Tract Infections
- 5.2.6 Other Indications
-
5.3 By End User
- 5.3.1 Hospitals and Intensive Care Units
- 5.3.2 Ambulatory Surgical and Diagnostic Centers
- 5.3.3 Nursing Homes and Maternity Centers
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 3M Company
- 6.1.2 Becton, Dickinson and Company
- 6.1.3 Fortive Corporation
- 6.1.4 Metall Zug Group (Belimed)
- 6.1.5 Cantel Medical
- 6.1.6 Getinge AB
- 6.1.7 Sotera Health
- 6.1.8 STERIS PLC
- 6.1.9 S. C. Johnson & Son Inc.
- 6.1.10 Tuttnauer
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityHospital Acquired Infection Control Industry Segmentation
As per the scope of the report, hospital-acquired infections are also nosocomial infections developed in hospitals and other healthcare facilities. These infections can occur up to 48 hours after hospital admission, up to three days after discharge, up to 30 days after an operation, or in a healthcare facility when the patient was admitted for reasons other than an infection. The Hospital Acquired Infection Control Market is segmented by Product (Sterilant, Disinfectants, and Other Products), Indication (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections, and Other Indications), End User (Hospitals and Intensive Care Units, Ambulatory Surgical and Diagnostic Centers, Nursing Homes and Maternity Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across significant global regions. The report offers the value (USD million) for the above segments.
| By Product | Sterilants | Heat Sterilization Equipment |
| Low Temperature Sterilization Equipment | ||
| Radiation Sterilization Equipment | ||
| Steam Sterilization | ||
| Other Sterilants | ||
| By Product | Disinfectants | |
| Other Products | ||
| By Indication | Hospital Acquired Pneumonia | |
| Bloodstream Infections | ||
| Surgical Site Infections | ||
| Gastrointestinal Infections | ||
| Urinary Tract Infections | ||
| Other Indications | ||
| By End User | Hospitals and Intensive Care Units | |
| Ambulatory Surgical and Diagnostic Centers | ||
| Nursing Homes and Maternity Centers | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Hospital Acquired Infection Control Market Research FAQs
How big is the Global Hospital Acquired Infection Control Market?
The Global Hospital Acquired Infection Control Market size is expected to reach USD 4.26 billion in 2024 and grow at a CAGR of 3.97% to reach USD 5.18 billion by 2029.
What is the current Global Hospital Acquired Infection Control Market size?
In 2024, the Global Hospital Acquired Infection Control Market size is expected to reach USD 4.26 billion.
Who are the key players in Global Hospital Acquired Infection Control Market?
3M Company, Becton, Dickinson and Company, Biomerieux SA, Sterigenics International LLC and Johnson and Johnson(Ethicon) are the major companies operating in the Global Hospital Acquired Infection Control Market.
Which is the fastest growing region in Global Hospital Acquired Infection Control Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Hospital Acquired Infection Control Market?
In 2024, the North America accounts for the largest market share in Global Hospital Acquired Infection Control Market.
What years does this Global Hospital Acquired Infection Control Market cover, and what was the market size in 2023?
In 2023, the Global Hospital Acquired Infection Control Market size was estimated at USD 4.10 billion. The report covers the Global Hospital Acquired Infection Control Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Hospital Acquired Infection Control Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Hospital Acquired Infection Control Industry Report
Statistics for the 2024 Hospital Acquired Infection Control market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Hospital Acquired Infection Control analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
